查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1825727

2025年全球內分泌檢測市場報告

Endocrine Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年內分泌檢測市場將強勁成長，到2029年將達到38.9億美元，複合年成長率為8.7%。預測期內的成長可歸因於內分泌疾病盛行率的上升、國防支出的增加、人口老化、認知度的提高和早期診斷以及認知度的提升。預測期內的主要趨勢包括生物標記檢測的進步、體學技術的整合、人工智慧和機器學習、品質保證和標準化以及合作研究和轉化醫學。

未來五年8.7%的預測成長率，較我們先前對該市場的預測略有下降0.8%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能導致瑞士和荷蘭研發的免疫測量分析儀和試劑價格上漲，阻礙先進內分泌檢測在美國的普及，導致代謝紊亂的檢測延遲和診斷實驗室成本上升。由於互惠關稅以及貿易緊張局勢和限制措施的加劇對全球經濟和貿易的負面影響，貿易摩擦的影響也將更加廣泛。

糖尿病盛行率的上升預計將推動內分泌檢測市場的成長。糖尿病是一組以高血糖 (葡萄糖) 水平為特徵的疾病，由於不良飲食、久坐不動的生活方式、遺傳因素和人口老化等因素，其盛行率正在上升。內分泌檢測，包括糖化血紅蛋白、空腹血糖和 C 肽等檢測，對於診斷糖尿病、監測血糖濃度以及評估胰島素的產生和敏感性至關重要。例如，2024 年 6 月，英國國家醫療服務體系 (NHS) 報告 40 歲以下糖尿病患者數量顯著增加，從 2022 年的 173,166 人增加到 2023 年的 216,440 人。這一激增表明年輕一代糖尿病患病率的趨勢令人擔憂。因此，糖尿病盛行率的上升刺激了對內分泌檢測解決方案的需求。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球內分泌測試：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球內分泌檢測市場：成長率分析
  • 全球內分泌檢測市場表現：規模與成長，2019-2024
  • 全球內分泌檢測市場預測：規模與成長，2024-2029年，2034年
  • 全球內分泌檢測：總目標市場（TAM）

第6章 市場細分

  • 全球內分泌檢測市場（按檢測類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 雌二醇（E2）檢測
  • 濾泡刺激素（FSH）檢測
  • 人類絨毛膜促性腺激素分泌（hCG）檢測
  • 黃體激素（LH）檢測
  • 脫氫表雄酮硫酸鹽（DHEAS）測試
  • 黃體酮檢測
  • 睪酮測試
  • 甲狀腺刺激素（TSH）檢測
  • 催乳素測試
  • 其他類型
  • 全球內分泌檢測市場：依技術、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 串聯式質譜質譜法
  • 免疫檢測
  • 單株和多株抗體技術
  • 感測器技術
  • 臨床化學
  • 其他技術
  • 全球內分泌檢測市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 臨床實驗室
  • 診斷中心
  • 其他最終用戶
  • 全球內分泌檢測市場：細分：雌二醇（E2）檢測（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 血清雌二醇檢測
  • 尿雌二醇檢測
  • 全球內分泌檢測市場：濾泡刺激素(FSH) 檢測類型細分、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • FSH血清檢測
  • FSH尿液檢查
  • 全球內分泌檢測市場：人類絨毛膜促性腺激素分泌(hCG) 檢測細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 定量hCG檢測
  • 定性 hCG 檢測
  • 全球內分泌檢測市場：黃體激素(LH) 檢測類型細分、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • LH血清檢測
  • 尿液促黃尿液檢查
  • 全球內分泌檢測市場：細分：脫氫表雄酮硫酸鹽 (DHEAS) 檢測，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 血清DHEAS檢測
  • 唾液脫氫表雄酮檢測
  • 全球內分泌檢測市場：依黃體素檢測類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 血清黃體素檢測
  • 尿液孕酮檢測
  • 全球內分泌檢測市場：細分：睪固酮檢測（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 免費睪固酮測試
  • 總睾酮測試
  • 全球內分泌檢測市場：促甲狀腺刺激素(TSH) 檢測細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • TSH血清檢測
  • TSH唾液測試
  • 全球內分泌檢測市場：細分：催乳素檢測（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 血清催乳素檢測
  • 血漿催乳素檢測
  • 全球內分泌檢測市場：按類型、實際和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 皮質醇測試
  • 胰島素檢測
  • 生長激素（GH）測試
  • 醛固酮測試

第7章 區域和國家分析

  • 全球內分泌檢測市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球內分泌檢測市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 內分泌檢測市場：競爭格局
  • 內分泌檢測市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Roche Holding Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • BioMerieux SA
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • SD Biosensor Inc.
  • Qiagen NV
  • Ortho Clinical Diagnostics
  • Kronus Inc.
  • Randox Laboratories Ltd.
  • Fujirebio Diagnostics Inc.
  • Inova Diagnostics Inc.
  • Sekisui Diagnostics LLC
  • Mercodia AB
  • ZEUS Scientific Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年內分泌檢測市場：提供新機會的國家
  • 2029年內分泌檢測市場：細分領域帶來新機會
  • 2029年內分泌檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r30136u

Endocrine testing involves the diagnostic assessment of hormone levels within the body, typically conducted through blood, urine, or saliva analyses, to evaluate the function of the endocrine system. These tests play a vital role in diagnosing a range of endocrine disorders, such as diabetes, thyroid disorders, adrenal insufficiency, and pituitary gland disorders, enabling healthcare providers to formulate appropriate treatment and management plans for affected patients.

The primary types of endocrine testing encompass various assessments including the estradiol (E2) test, follicle-stimulating hormone (FSH) test, human chorionic gonadotropin (HCG) hormone test, luteinizing hormone (LH) test, dehydroepiandrosterone sulfate (DHEAS) test, progesterone test, testosterone test, thyroid-stimulating hormone (TSH) test, prolactin test, among others. For instance, the Estradiol (E2) Test involves a blood test to measure estradiol levels in the body. These tests utilize diverse technologies such as tandem mass spectrometry, immunoassays, monoclonal and polyclonal antibody technologies, sensor technology, clinical chemistry, among others, and are commonly conducted in hospitals, clinical laboratories, diagnostic centers, and similar healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The endocrine testing market research report is one of a series of new reports from The Business Research Company that provides endocrine testing market statistics, including endocrine testing industry global market size, regional shares, competitors with a endocrine testing market share, detailed endocrine testing market segments, market trends and opportunities, and any further data you may need to thrive in the endocrine testing industry. This endocrine testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endocrine testing market size has grown strongly in recent years. It will grow from $2.55 billion in 2024 to $2.79 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to discovery of hormones and endocrine pathways, diagnostic test standardization, public health initiatives, and patient advocacy and empowerment.

The endocrine testing market size is expected to see strong growth in the next few years. It will grow to $3.89 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to growing prevalence of endocrine disorders, increased defense spending, aging population, awareness and early diagnosis, and increased awareness. Major trends in the forecast period include advancements in biomarker detection, integration of omics technologies, artificial intelligence and machine learning, quality assurance and standardization, and collaborative research and translational medicine.

The forecast of 8.7% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of advanced endocrine testing by inflating prices of immunoassay analyzers and reagents developed in Switzerland and the Netherlands, resulting in slower metabolic disorder detection and higher diagnostic lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diabetes is expected to drive the growth of the endocrine testing market. Diabetes is a group of diseases characterized by high blood sugar (glucose) levels, and its prevalence is rising due to factors such as poor dietary habits, sedentary lifestyles, genetic factors, and an aging population. Endocrine testing, including tests like hemoglobin A1c, fasting plasma glucose, and C-peptide, is essential in diagnosing diabetes, monitoring glucose levels, and evaluating insulin production and sensitivity. For example, in June 2024, the National Health Service (NHS) reported a significant increase in diabetes cases among individuals under 40, with the number rising from 173,166 in 2022 to 216,440 in 2023. This surge indicates a concerning trend in diabetes prevalence among younger populations. As a result, the growing prevalence of diabetes is fueling the demand for endocrine testing solutions.

Key players in the endocrine testing market are focusing on developing point-of-care testing solutions to enhance accessibility and efficiency in diagnosing endocrine disorders. Point-of-care testing enables rapid results, aiding in prompt diagnosis and management of conditions such as heart failure in patients displaying symptoms such as shortness of breath and fatigue. For example, in April 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced a point-of-care NT-proBNP test in India. This test is specifically tailored for screening diabetes patients at risk of cardiovascular diseases such as heart failure (HF), facilitating early detection and intervention. It empowers clinicians to identify high-risk T2D patients promptly and initiate timely treatment discussions, ultimately leading to improved outcomes and patient well-being.

In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics, although the financial details remain undisclosed. This acquisition aligns with Tolmar's focus on pediatric endocrinology and men's health, augmenting their portfolio of specialty pharmaceutical products. Clarus Therapeutics, a US-based pharmaceutical company, specializes in developing and commercializing therapies for individuals with endocrine disorders.

Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

North America was the largest region in the endocrine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endocrine testing market consists of revenues earned by entities by providing services such as hormone level testing, thyroid function testing, diabetes testing, adrenal function testing, reproductive hormone testing, pituitary function testing, and bone metabolism testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine testing market also includes sales of assay kits, analyzers, point-of-care testing devices, reagents, software solutions, quality control materials, and calibrators and controls. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endocrine Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endocrine testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endocrine testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endocrine testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Estradiol (E2) Test; Follicle Stimulating Hormone (FSH) Test; Human Chorionic Gonadotropin (hCG) Hormone Test; Luteinizing Hormone (LH) Test; Dehydroepiandrosterone Sulfate (DHEAS) Test; Progesterone Test; Testosterone Test; Thyroid Stimulating Hormone (TSH) Test; Prolactin Test; Other Types
  • 2) By Technology: Tandem Mass Spectrometry; Immunoassay; Monoclonal And Polyclonal Antibody Technologies; Sensor Technology; Clinical Chemistry; Other Technologies
  • 3) By End-User: Hospitals; Clinical Laboratories; Diagnostic Centers; Other End-Users
  • Subsegments:
  • 1) By Estradiol (E2) Test: Serum Estradiol Test; Urinary Estradiol Test
  • 2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test; FSH Urine Test
  • 3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test; Qualitative hCG Test
  • 4) By Luteinizing Hormone (LH) Test: LH Serum Test; LH Urine Test
  • 5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test; Saliva DHEAS Test
  • 6) By Progesterone Test: Serum Progesterone Test; Urinary Progesterone Test
  • 7) By Testosterone Test: Free Testosterone Test; Total Testosterone Test
  • 8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test; TSH Saliva Test
  • 9) By Prolactin Test: Serum Prolactin Test; Plasma Prolactin Test
  • 10) By Other Types: Cortisol Test; Insulin Test; Growth Hormone (GH) Test; Aldosterone Test
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Roche Holding; Siemens Healthineers; Quest Diagnostics; Agilent Technologies Inc.; PerkinElmer Inc.; BioMerieux SA; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; SD Biosensor Inc.; Qiagen N.V.; Ortho Clinical Diagnostics; Kronus Inc.; Randox Laboratories Ltd.; Fujirebio Diagnostics Inc.; Inova Diagnostics Inc.; Sekisui Diagnostics LLC; Mercodia AB; ZEUS Scientific Inc.; IBL International; Monobind Inc.; Agilus Diagnostics; Tosoh Bioscience Inc.; DiaSorin S.p.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endocrine Testing Market Characteristics

3. Endocrine Testing Market Trends And Strategies

4. Endocrine Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Endocrine Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Endocrine Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Endocrine Testing Market Growth Rate Analysis
  • 5.4. Global Endocrine Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Endocrine Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Endocrine Testing Total Addressable Market (TAM)

6. Endocrine Testing Market Segmentation

  • 6.1. Global Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Estradiol (E2) Test
  • Follicle Stimulating Hormone (FSH) Test
  • Human Chorionic Gonadotropin (hCG) Hormone Test
  • Luteinizing Hormone (LH) Test
  • Dehydroepiandrosterone Sulfate (DHEAS) Test
  • Progesterone Test
  • Testosterone Test
  • Thyroid Stimulating Hormone (TSH) Test
  • Prolactin Test
  • Other Types
  • 6.2. Global Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tandem Mass Spectrometry
  • Immunoassay
  • Monoclonal And Polyclonal Antibody Technologies
  • Sensor Technology
  • Clinical Chemistry
  • Other Technologies
  • 6.3. Global Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinical Laboratories
  • Diagnostic Centers
  • Other End-Users
  • 6.4. Global Endocrine Testing Market, Sub-Segmentation Of Estradiol (E2) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Estradiol Test
  • Urinary Estradiol Test
  • 6.5. Global Endocrine Testing Market, Sub-Segmentation Of Follicle Stimulating Hormone (FSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • FSH Serum Test
  • FSH Urine Test
  • 6.6. Global Endocrine Testing Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG) Hormone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Quantitative hCG Test
  • Qualitative hCG Test
  • 6.7. Global Endocrine Testing Market, Sub-Segmentation Of Luteinizing Hormone (LH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • LH Serum Test
  • LH Urine Test
  • 6.8. Global Endocrine Testing Market, Sub-Segmentation Of Dehydroepiandrosterone Sulfate (DHEAS) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum DHEAS Test
  • Saliva DHEAS Test
  • 6.9. Global Endocrine Testing Market, Sub-Segmentation Of Progesterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Progesterone Test
  • Urinary Progesterone Test
  • 6.10. Global Endocrine Testing Market, Sub-Segmentation Of Testosterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Free Testosterone Test
  • Total Testosterone Test
  • 6.11. Global Endocrine Testing Market, Sub-Segmentation Of Thyroid Stimulating Hormone (TSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • TSH Serum Test
  • TSH Saliva Test
  • 6.12. Global Endocrine Testing Market, Sub-Segmentation Of Prolactin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum Prolactin Test
  • Plasma Prolactin Test
  • 6.13. Global Endocrine Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cortisol Test
  • Insulin Test
  • Growth Hormone (GH) Test
  • Aldosterone Test

7. Endocrine Testing Market Regional And Country Analysis

  • 7.1. Global Endocrine Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Endocrine Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endocrine Testing Market

  • 8.1. Asia-Pacific Endocrine Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endocrine Testing Market

  • 9.1. China Endocrine Testing Market Overview
  • 9.2. China Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endocrine Testing Market

  • 10.1. India Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endocrine Testing Market

  • 11.1. Japan Endocrine Testing Market Overview
  • 11.2. Japan Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endocrine Testing Market

  • 12.1. Australia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endocrine Testing Market

  • 13.1. Indonesia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endocrine Testing Market

  • 14.1. South Korea Endocrine Testing Market Overview
  • 14.2. South Korea Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endocrine Testing Market

  • 15.1. Western Europe Endocrine Testing Market Overview
  • 15.2. Western Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endocrine Testing Market

  • 16.1. UK Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endocrine Testing Market

  • 17.1. Germany Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endocrine Testing Market

  • 18.1. France Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endocrine Testing Market

  • 19.1. Italy Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endocrine Testing Market

  • 20.1. Spain Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endocrine Testing Market

  • 21.1. Eastern Europe Endocrine Testing Market Overview
  • 21.2. Eastern Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endocrine Testing Market

  • 22.1. Russia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endocrine Testing Market

  • 23.1. North America Endocrine Testing Market Overview
  • 23.2. North America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endocrine Testing Market

  • 24.1. USA Endocrine Testing Market Overview
  • 24.2. USA Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endocrine Testing Market

  • 25.1. Canada Endocrine Testing Market Overview
  • 25.2. Canada Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endocrine Testing Market

  • 26.1. South America Endocrine Testing Market Overview
  • 26.2. South America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endocrine Testing Market

  • 27.1. Brazil Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endocrine Testing Market

  • 28.1. Middle East Endocrine Testing Market Overview
  • 28.2. Middle East Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endocrine Testing Market

  • 29.1. Africa Endocrine Testing Market Overview
  • 29.2. Africa Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endocrine Testing Market Competitive Landscape And Company Profiles

  • 30.1. Endocrine Testing Market Competitive Landscape
  • 30.2. Endocrine Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Roche Holding Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

31. Endocrine Testing Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. PerkinElmer Inc.
  • 31.3. BioMerieux SA
  • 31.4. Beckman Coulter Inc.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. SD Biosensor Inc.
  • 31.7. Qiagen N.V.
  • 31.8. Ortho Clinical Diagnostics
  • 31.9. Kronus Inc.
  • 31.10. Randox Laboratories Ltd.
  • 31.11. Fujirebio Diagnostics Inc.
  • 31.12. Inova Diagnostics Inc.
  • 31.13. Sekisui Diagnostics LLC
  • 31.14. Mercodia AB
  • 31.15. ZEUS Scientific Inc.

32. Global Endocrine Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endocrine Testing Market

34. Recent Developments In The Endocrine Testing Market

35. Endocrine Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Endocrine Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Endocrine Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Endocrine Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer